Phibro Animal Health (PAHC) Net Income Growth (5y) (2017 - 2026)
Phibro Animal Health (PAHC) Net Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.59% |
| Dec 31, 2025 | 16.49% |
| Sep 30, 2025 | 16.61% |
| Jun 30, 2025 | 18.97% |
| Mar 31, 2025 | 9.11% |
| Dec 31, 2024 | -23.17% |
| Sep 30, 2024 | 22.63% |
| Jun 30, 2024 | -53.09% |
| Mar 31, 2024 | -10.76% |
| Dec 31, 2023 | -38.72% |
| Sep 30, 2023 | -20.03% |
| Jun 30, 2023 | -16.43% |
| Mar 31, 2023 | -12.73% |
| Dec 31, 2022 | 0.50% |
| Sep 30, 2022 | -24.67% |
| Jun 30, 2022 | -13.41% |
| Mar 31, 2022 | -5.64% |
| Dec 31, 2021 | 5.42% |
| Sep 30, 2021 | -11.71% |
| Jun 30, 2021 | -0.37% |